Iain Charles Wilcock
Direttore/Membro del Consiglio presso Oxxon Therapeutics, Inc.
Profilo
Iain Charles Wilcock Iain joined the Seventure Life Sciences team in 2008 as a Venture Partner.
He is responsible for investments in the United Kingdom (UK) and Ireland.
Prior to joining Seventure Partners, Iain created and managed Quester Capital’s biotech and health venture capital activity for over 10 years.
In 2007, Iain founded Vela Venture Partners to advise venture capitalists in the UK.
As a former Director, he has served on the boards of several biotechnology, medtech and cleantech companies such as Vivacta, Avidex, Oxxon, Lectus, and Xention.
He is a member of the British Venture Capital Association, the BioIndustry Association, the Industrial Biotech Leadership Forum and UNICO.
Iain was appointed in 2008 to the Strategic Intellectual Property Policy Advisory Board to advise the UK Intellectual Property Office.
Iain graduated in Biochemistry from the University of Oxford, is a qualified tax expert in the UK and graduated from the London Business School.
Posizioni attive di Iain Charles Wilcock
| Società | Posizione | Inizio |
|---|---|---|
Oxxon Therapeutics, Inc.
 Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Direttore/Membro del Consiglio | - |
Kebony AS
 Kebony AS Forest ProductsNon-Energy Minerals Kebony AS operates as a holding company which engages in the research, development, and production of wooden products. The firm’s products include cladding, decking, construction, roof and rough sawn. The company was founded in 1997 and is headquartered in Oslo, Norway. | Direttore/Membro del Consiglio | - |
Seventure Partners SA
 Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Investitore di Private Equity | 01/01/2008 |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | - |
Brathew Ltd.
 Brathew Ltd. Engineering & ConstructionIndustrial Services Brathew Ltd. develops building projects. | Direttore/Membro del Consiglio | 21/07/2012 |
Precedenti posizioni note di Iain Charles Wilcock
| Società | Posizione | Fine |
|---|---|---|
Nesta Investment Management LLP
 Nesta Investment Management LLP Investment ManagersFinance Nesta Investment Management LLP. (NESTA Investments) subsidiary of Nesta formerly NESTA, is a venture capital firm founded in 1998. The firm is headquartered in London city United Kingdom. | Investitore di Private Equity | 01/01/2010 |
Avidex Ltd.
 Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Direttore/Membro del Consiglio | 04/12/2008 |
SPARK Venture Management Ltd.
 SPARK Venture Management Ltd. Investment ManagersFinance SPARK Venture Management Ltd. (SPARK Ventures) is a venture capital subsidiary of Querist Ltd. founded in 1989 by Kiko Duffy and Thomas Alfred Teichman. The firm is headquartered in London, United Kingdom. | Head-Equity Investments | 01/03/2007 |
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Direttore/Membro del Consiglio | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Iain Charles Wilcock
| University of Oxford | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
SPARK Venture Management Ltd.
SPARK Venture Management Ltd. Investment ManagersFinance SPARK Venture Management Ltd. (SPARK Ventures) is a venture capital subsidiary of Querist Ltd. founded in 1989 by Kiko Duffy and Thomas Alfred Teichman. The firm is headquartered in London, United Kingdom. | Finance |
Oxxon Therapeutics, Inc.
Oxxon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Oxxon Therapeutics, Inc. develops and manufactures antigen-specific immunotherapies to treat patients with chronic infectious diseases and cancer. The company has three development programs in hepatitis, melanoma, and HIV. Oxxon Therapeutics was founded in 1999 by Dr. Joerg Schneider and is located at Oxford, UK. | Health Technology |
Avidex Ltd.
Avidex Ltd. Pharmaceuticals: MajorHealth Technology Avidex Ltd. develops and discovers drugs for the treatment of cancer and autoimmune diseases. The company develops small molecule and protein therapeutics involving T cell receptors. Avidex was founded in 1999 and is headquartered in Abingdon, UK | Health Technology |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Health Technology |
Lectus Therapeutics Ltd.
 Lectus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lectus Therapeutics Ltd. Developed ion channel modulators and therapeutics. The company was founded in December 2002 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Nesta Investment Management LLP
Nesta Investment Management LLP Investment ManagersFinance Nesta Investment Management LLP. (NESTA Investments) subsidiary of Nesta formerly NESTA, is a venture capital firm founded in 1998. The firm is headquartered in London city United Kingdom. | Finance |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
PhosphonicS Ltd.
 PhosphonicS Ltd. BiotechnologyHealth Technology PhosphonicS Ltd. develops products for separation and purification of solid materials. Its products include screening kits, bulk materials and pre-engineered solutions. The firm serves Pharmaceuticals, Chemicals, Mining Refineries, Metal Recovery and Recycling, Electronics and Natural Extracts industries. The company was founded in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Kebony AS
Kebony AS Forest ProductsNon-Energy Minerals Kebony AS operates as a holding company which engages in the research, development, and production of wooden products. The firm’s products include cladding, decking, construction, roof and rough sawn. The company was founded in 1997 and is headquartered in Oslo, Norway. | Non-Energy Minerals |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark. | Health Technology |
Seventure Partners SA
Seventure Partners SA Investment ManagersFinance Seventure Partners SA (Seventure) is a Venture Capital firm, a subsidiary of Natixis SA founded in 1997. Seventure Partners SA is headquartered in Paris. | Finance |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Brathew Ltd.
Brathew Ltd. Engineering & ConstructionIndustrial Services Brathew Ltd. develops building projects. | Industrial Services |
- Borsa valori
- Insiders
- Iain Charles Wilcock